Logos Global Management LP Argenx Se Transaction History
Logos Global Management LP
- $1.07 Billion
- Q2 2024
A detailed history of Logos Global Management LP transactions in Argenx Se stock. As of the latest transaction made, Logos Global Management LP holds 135,000 shares of ARGX stock, worth $80.2 Million. This represents 5.45% of its overall portfolio holdings.
Number of Shares
135,000
Previous 135,000
-0.0%
Holding current value
$80.2 Million
Previous $58.1 Million
-0.0%
% of portfolio
5.45%
Previous 5.45%
Shares
2 transactions
Others Institutions Holding ARGX
# of Institutions
393Shares Held
31.8MCall Options Held
361KPut Options Held
449K-
Price T Rowe Associates Inc Baltimore, MD5.6MShares$3.33 Billion0.29% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI3.51MShares$2.09 Billion2.99% of portfolio
-
Janus Henderson Group PLC London, X02.47MShares$1.47 Billion0.58% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD1.92MShares$1.14 Billion0.52% of portfolio
-
Capital World Investors Los Angeles, CA1.51MShares$898 Million0.11% of portfolio
About ARGENX SE
- Ticker ARGX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,323,800
- Market Cap $32.9B
- Description
- argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...